| Literature DB >> 32393285 |
Rebekah R Jacob1, Angeline Gacad2, Margaret Padek2, Graham A Colditz3, Karen M Emmons4, Jon F Kerner5, David A Chambers6, Ross C Brownson2,3.
Abstract
BACKGROUND: There is a continued need to evaluate training programs in dissemination and implementation (D&I) research. Scientific products yielded from trainees are an important and objective measure to understand the capacity growth within the D&I field. This study evaluates our mentored training program in terms of scientific productivity among applicants.Entities:
Keywords: Dissemination and implementation; Dissemination and implementation research training; Evaluation; Scientific productivity
Mesh:
Year: 2020 PMID: 32393285 PMCID: PMC7216589 DOI: 10.1186/s13012-020-00994-0
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Applicant characteristics (N = 102), Mentored Training for Dissemination and Implementation Research in Cancer
| Total ( | Fellow ( | Nonfellow ( | ||
|---|---|---|---|---|
| Gender | 0.914 | |||
| Female | 82 (80.4) | 44 (80.0) | 38 (80.9) | |
| Male | 20 (19.6) | 11 (20.0) | 9 (19.1) | |
| Cancer area focus | 0.457 | |||
| Detection | 16 (15.7) | 11 (20.0) | 5 (10.6) | |
| Prevention | 49 (48.0) | 24 (43.6) | 25 (53.2) | |
| Survivorship | 18 (17.6) | 11 (20.0) | 7 (14.9) | |
| Treatment | 19 (18.6) | 9 (16.4) | 10 (21.3) | |
| Position | 0.475 | |||
| Associate professor or professor | 15 (14.7) | 10 (18.2) | 5 (10.6) | |
| Assistant professor | 47 (46.1) | 27 (49.1) | 20 (42.6) | |
| Post-doctoral or research fellow | 22 (21.6) | 10 (18.2) | 12 (25.5) | |
| Others | 18 (17.6) | 8 (14.5) | 10 (21.3) | |
| Home institution within the USA | 0.242 | |||
| No | 15 (14.7) | 6 (10.9) | 9 (19.1) | |
| Yes | 87 (85.3) | 49 (89.1) | 38 (80.9) | |
| Years from an undergraduate degree at the time of application, mean (SD) | 17.9 (6.7) | 18.2 (6.3) | 17.4 (7.2) | 0.565 |
| Application year (cohort) | 0.011 | |||
| 2014 | 21 (20.6) | 13 (23.6) | 8 (17.0) | |
| 2015 | 22 (21.6) | 15 (27.3) | 7 (14.9) | |
| 2016 | 18 (17.6) | 13 (23.6) | 5 (10.6) | |
| 2017 | 41 (40.2) | 14 (25.5) | 27 (57.4) |
ap values from independent samples t tests for continuous data and Pearson chi-square tests for categorical data
Applicant funding and publication (N = 102), Mentored Training for Dissemination and Implementation Research in Cancer
| Total | Fellow | Nonfellow | ||
|---|---|---|---|---|
| Grant funding in RePORTER (US applicants only, | ||||
| Before or at the application year | ||||
| Grant funding, | 0.117 | |||
| No | 49 (56.3) | 24 (49.0) | 25 (65.8) | |
| Yes | 38 (43.7) | 25 (51.0) | 13 (34.2) | |
| D&I grant funding, | 0.009 | |||
| No | 79 (90.8) | 41 (83.7) | 38 (100.0) | |
| Yes | 8 (9.2) | 8 (16.3) | 0 (0.0) | |
| Afterb the application year | ||||
| Grant funding, | 0.013 | |||
| No | 64 (73.6) | 31 (63.3) | 33 (86.8) | |
| Yes | 23 (26.4) | 18 (36.7) | 5 (13.2) | |
| D&I grant funding, | 0.042 | |||
| No | 75 (86.2) | 39 (79.6) | 36 (94.7) | |
| Yes | 12 (13.8) | 10 (20.4) | 2 (5.3) | |
| Publications indexed in SCOPUS (all applicants, | ||||
| Before or at the application year | ||||
| D&I publication | 0.014 | |||
| No | 75 (73.5) | 35 (63.6) | 40 (85.1) | |
| Yes | 27 (26.5) | 20 (36.4) | 7 (14.9) | |
| Afterc the application year | ||||
| Published D&I afterc application | <0.001 | |||
| No | 51 (50.0) | 19 (34.5) | 32 (68.1) | |
| Yes | 51 (50.0) | 36 (65.5) | 15 (31.9) | |
ap values from Pearson chi-square tests
bAfter represents the time between the application year and September 2019 when data was collected
cAfter represents the time between the application year and July 2019 when data was collected
US applicant awarded federally funded grant between the application year and September 2019 (N = 87)
| Model 1 | Model 2 | Model 3 | Model 4 | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| MT-DIRC | ||||||||
| Nonfellow (ref) | ||||||||
| Fellow | 1.1 (0.6) | 3.0 (0.99–10.2) | 1.1 (0.6) | 3.1 (0.98–11.0) | ||||
| Timea | 0.3 (0.2) | 1.4 (0.9–2.1) | 0.4 (0.2) | 1.5 (0.9–2.4) | 0.3 (0.2) | 1.4 (0.9–2.1) | 0.40 (0.2) | 1.5 (0.96–2.4) |
| Cancer research area | ||||||||
| Treatment (ref) | ||||||||
| Survivorship | − 0.9 (0.86) | 0.4 (0.1–2.0) | − 0.8 (0.9) | 0.5 (0.1–2.6) | ||||
| Detection | − 0.8 (0.85) | 0.5 (0.1–2.4) | − 0.7 (0.9) | 0.5 (0.1–2.6) | ||||
| Prevention | − 1.1 (0.71) | 0.3 (0.1–1.3) | − 1.1 (0.7) | 0.3 (0.1–1.3) | ||||
| Previous grant funding | ||||||||
| No (ref) | ||||||||
| Yes | 0.6 (0.5) | 1.9 (0.7–5.3) | 0.6 (0.5) | 1.9 (0.7–5.7) | ||||
aTime in years from the application year to September 2019, when data was collected. Bold values are significant at p < 0.05
Applicant published D&I article between the application year and July 2019 (N = 102)
| Model 1 | Model 2 | Model 3 | Model 4 | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| MT-DIRC | ||||||||
| Nonfellow (ref) | ||||||||
| Fellow | ||||||||
| Timea | 0.1 (0.2) | 1.1 (0.8–1.6) | 0.1 (0.2) | 1.1 (0.8–1.6) | 0.1 (0.2) | 1.1 (0.7–1.6) | 0.1 (0.2) | 1.1 (0.7–1.6) |
| Previous D&I publication | ||||||||
| No (ref) | ||||||||
| Yes | ||||||||
| Years since undergraduate degree | ||||||||
aTime in years from application to July 2019, when data was collected. Bold terms are significant at p < 0.05